Medication info

Optabella Eye Drops (Fluorometholone) (Single Use), Optabella Eye Drops (Fluorometholone)

Prescription medicationSuspensionEye drops
Ingredient · strength
Fluorometholone›1mg / 1mL
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
[Single Use] A light milky-white aqueous suspension in a colorless and transparent plastic container [Multi Use] A light milky-white aqueous suspension in a translucent plastic container
Packaging
[Single Use] 0.4mL tube x 30 tubes [Multi Use] 5mL/bottle
Approval status
Active

MFDS item code 201800529 · Notified 2018.01.29 · Insurance code 643307981,643308001

Summary

Main use
Treatment of inflammatory diseases of the external and anterior eye (such as conjunctivitis and keratitis)
Who applies the drops
Adults
Adult eye dose
Instill 1–2 drops per dose, 2–4 times daily. Adjust the dose as appropriate according to symptoms. Discard any remaining solution and the container immediately after use. (For single-use products only)

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of inflammatory diseases of the external and anterior eye (such as conjunctivitis and keratitis)

  • Blepharitis
  • conjunctivitis
  • keratitis
  • scleritis
  • episcleritis
  • iritis
  • iridocyclitis
  • uveitis
  • postoperative inflammation
View approved original text

This medication is used to treat various inflammatory diseases that occur in the outer and inner parts of the eye. The 0.02% eye drop is effective for external inflammatory conditions such as blepharitis, conjunctivitis, keratitis, scleritis, and episcleritis. The 0.1% eye drop can be used not only for external conditions but also for anterior segment inflammation and postoperative inflammation such as iritis, iridocyclitis, and uveitis. It helps alleviate symptoms associated with these various eye inflammations.

How to apply drops

Adult eye dose

Instill 1–2 drops per dose, 2–4 times daily. Adjust the dose as appropriate according to symptoms. Discard any remaining solution and the container immediately after use. (For single-use products only)

Precautions

This medication should not be used in patients with viral conjunctival diseases, fungal eye diseases, mycobacterial infections, chronic blepharitis, or those who are hypersensitive to the drug. It is generally not recommended for patients with corneal epithelial desquamation or ulcers, tuberculous or purulent eye diseases, glaucoma patients, and infants under 2 years of age; if it must be used, it should be administered very cautiously. Long-term use may lead to increased intraocular pressure or glaucoma, and damage to the optic nerve such as vision loss, so regular intraocular pressure checks are necessary. Additionally, the worsening of herpetic keratitis, fungal infections, or infections may occur, and there is a risk of corneal perforation, so appropriate treatment is necessary if infection symptoms are present. Long-term use may result in posterior cataract or secondary eye infections, necessitating caution. During acute purulent eye infections, the use of this drug may mask or worsen symptoms, so caution is required. This medication contains phosphate and may occasionally cause corneal calcification in patients with severe corneal damage. Post-cataract surgery, wound healing may be delayed or blisters may form, and long-term use may lead to decreased pituitary and adrenal function. If hypersensitivity symptoms occur, discontinue use immediately. If infected with chickenpox or measles while using this medication, it can lead to serious consequences, so medical history and vaccination status must be checked prior to administration to minimize infection risk. Caution is advised when using on reddened eyes without a physician's diagnosis, as there is a risk of blindness. Patients with a history of herpes simplex should undergo slit-lamp examinations frequently, and regular intraocular pressure checks are necessary with long-term administration exceeding 10 days. If inflammation or pain persists or worsens for more than 48 hours, discontinue use immediately and consult a physician. Contact lens wearers should remove their lenses before instillation and wait at least 30 minutes before reinserting them. Instillation may temporarily blur vision, so driving or operating hazardous machinery should be avoided until vision is clear. Coadministration with CYP3A4 inhibitors may increase the risk of systemic side effects, requiring careful observation. Pregnant women or those who may become pregnant should avoid long-term use, and nursing mothers should refrain from use; if necessary, breastfeeding should be discontinued during administration. Safety for use in infants and young children has not been established, so caution is advised. Elderly patients should be particularly cautious due to decreased physiological functions. This medication is for ophthalmic use only; avoid direct contact of the container tip with the eye. Shake well before use, avoid communal use to prevent contamination, and single-use products must be used immediately after opening, discarding any leftovers. Store in a tightly closed container away from air and moisture, and keep at room temperature between 1°C and 30°C to maintain the medication's effectiveness longer.

Side effects

Optic nerve damage, vision loss, visual field loss, glaucoma, increased intraocular pressure, corneal herpes, fungal corneal infection, Pseudomonas infection, corneal ulcer, corneal perforation, posterior subcapsular cataract, secondary ocular infection, exacerbation of acute purulent ocular infection, acute uveitis, keratitis, conjunctivitis, corneal ulcer, mydriasis, conjunctival congestion, accommodaion paralysis, ptosis, corneal calcification, delayed wound healing, increased vesicle formation, suppression of pituitary and adrenal cortex function, hypersensitivity symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is best kept at room temperature between 1°C and 30°C. This will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

[Single Use] A light milky-white aqueous suspension in a colorless and transparent plastic container [Multi Use] A light milky-white aqueous suspension in a translucent plastic container

Package unit

[Single Use] 0.4mL tube x 30 tubes [Multi Use] 5mL/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.